Biomarker validation programs that must deliver consistent results across global trial sites. Complex assays validated to withstand regulatory scrutiny. Flow cytometry panels harmonized between hemispheres.
Scientific decisions that can’t wait for vendor delays.
Your most ambitious research deserves laboratory partners who understand these challenges.
At Cerba Research, we combine deep scientific expertise with cutting-edge technology to support your critical decisions from discovery through commercialization. 12 specialty laboratories across five continents, backed by a global central laboratory network, delivering customized solutions without compromising on scientific rigor.
Modern oncology and immunology trials demand expert pathology interpretation. From PD-L1 expression to multiplex tumor microenvironment analysis, histopathology and IHC provide the critical tissue-based insights that guide precision medicine. Our global network of board-certified pathologists and state-of-the-art platforms ensures consistent, reproducible results across your trial sites.
From companion diagnostics to exploratory biomarkers, we provide the histopathology expertise that transforms tissue samples into actionable clinical insights.
Routine, Molecular Biology,
Bioanalytical Lab, Flow
Cytometry, Microbiology
Industriepark-Zwijnaarde 3,
9052, Belgium
Genetics/NGS, Molecular Biology,
IVD, Flow Cytometry,
Histopathology/
IHC, Virology, Biorepository, BSL3
Paris:
Zac des Epineaux 10 Avenue Rolland Moreno CS 51312 95740, FREPILLON, France
Quality Charter
Montpellier:
126 Rue Emile Baudot,
34000, France
Routine, Genetics/NGS, Molecular
Biology, Virology, Microbiology,
BSL3, Biorepository
Routine, Genetics/NGS, Molecular Biology,
Flow Cytometry,
Bioanalytical Lab/PK,
Histopathology/IHC
Routine, Genetics/NGS, Flow
Cytometry, Histopathology/IHC Lab,
Routine, Molecular Biology,
Flow Cytometry, Virology
Shinjuku I-Land-Tower 10F
6-5-1, Nishishinjuku, shinjuku-ku
163-1310, Japan
BSL3, Pre-clinical, Molecular
Biology, Genetics/NGS,
Pathology, Virology
Rotterdam:
Rotterdam Science Tower
Marconistraat 16
3029 AK, The Netherlands
Rijswijk:
Visseringlaan 25
2288 ER, The Netherlands
Schaijk:
Nistelrooise Baan 3
5374 RE, The Netherlands
10 Nevada Drive
Lake Success, NY 11042, USA
Routine, Genetics/NGS,
Molecular Biology, IVD, Flow
Cytometry, Bioanalytical Lab/PK,
Histopathology/IHC, Virology
3150 Rue Delaunay
Laval, QC, Canada, H7L 5E1
Routine, Genetics/NGS,
Molecular Biology, IVD, Flow
Cytometry, Bioanalytical Lab/PK,
Histopathology/IHC, Virology
Birkdale building 2
Riverpark Business Park
Mowbray, South Africa
95 King Cetshwayo Highway
Block A, 2nd Floor Westridge
4001, South Africa
| North America | Europe | Asia-Pacific | Africa |
|---|---|---|---|
| New York, Montreal | Paris, Ghent, Rotterdam, Montpellier | Shanghai, Taipei, Sydney, Japan | Johannesburg partnership |
| New York (histopathology/IHC, flow cytometry: Cytek Aurora, NGS), Montreal (bioanalytical: PK/ADA/immunogenicity, immunoassays) | Paris/Frépillon (Complete platform: IHC/multiplex, flow cytometry, NGS, AAV testing, bioanalytical services), Ghent (bioanalytical, flow, immunoassays), Rotterdam (pre-clinical, pathology, BSL3), Montpellier (histopathology/IHC/Nanostring) | Shanghai (flow, NGS, IHC, bioanalysis), Taipei (flow, NGS, IHC), Sydney (flow cytometry) | Johannesburg partnership (BSL3, infectious disease, flow cytometry) |
Specialized expertise where complexity meets innovation
210+ trials since 2018
75% with specialty testing
32 market authorizations in both solid and liquid tumors
400+ trials since 2018
75% with specialty testing
BSL3 network
27 market authorizations
Expertise in TB, HIV, RSV, COVID-19
50+ trials since 2018
85% with specialty testing
CAR-T, TCR-T, CAR-NK, AAV, gene editing support
5 market authorizations including 3 CAR-T therapies
125+ trials since 2018
50% with specialty testing
Expertise in IBD, osteoarthritis, autoimmune diseases, atopic dermatitis
230+ trials since 2018
Customized biomarker strategies
Gene therapy validation
44 market authorizations
Expertise in rare neoplasms, infectious or parasitic diseases, skin diseases
Specialized testing
Biomarker discovery
Advanced genomics support
Explore Metabolic capabilities
Discover Neurology capabilities
Every cell therapy program faces endless analytical challenges.
How do you monitor CAR-T persistence across diverse patient populations? How do you validate vector copy number with regulatory confidence? How do you harmonize complex flow cytometry panels across global sites? How do you ensure anti-AAV antibodies don’t compromise gene therapy efficacy?
Cell and gene therapies demand specialized laboratory expertise at every development stage. Our comprehensive guide reveals the analytical strategies that have supported 50+ CGT trials and 5 market authorizations, including 3 CAR-T therapies.
What you’ll discover in our guide:
Purpose-built excellence in Frépillon, Paris
This flagship facility represents the pinnacle of specialty laboratory technology. Opened in 2024, this 23,000 square meter laboratory houses the most comprehensive array of advanced testing platforms in Europe, combining cutting-edge instrumentation with deep scientific expertise.
Key capabilities:
Our specialist scientists work with you from protocol design to optimize biomarker strategies, develop fit-for-purpose assays, and leverage proven methodologies from hundreds of successful trials. From histopathology validation to complex flow panels, early scientific consultation ensures your testing strategy aligns with regulatory expectations.
When your trial demands both advanced biomarker testing and routine safety monitoring, our integrated platform eliminates coordination headaches. One partner, one quality system, seamless data flow. Our global central laboratory network → provides comprehensive routine testing alongside specialty capabilities.
Fourteen specialty laboratories backed by deep expertise in oncology, infectious diseases, cell & gene therapy, and immunology. Harmonized SOPs and centralized scientific oversight ensure consistent excellence across continents. Our technology breadth—from IHC to NGS to AAV testing—means you never compromise on capability.
Whether you’re developing a companion diagnostic requiring validated IHC protocols, a CAR-T therapy demanding complex flow cytometry panels, a biologic needing comprehensive immunogenicity testing, or a gene therapy requiring AAV antibody screening, our specialty laboratory services provide the scientific expertise and global infrastructure you need.
